| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |